Diagnostic and therapeutic potential of exosomes in Alzheimer’s disease

Tânia Soares Martins,Dário Trindade,Margarida Vaz,Inês Campelo,Martim Almeida,Guilherme Trigo,Odete A. B. da Cruz e Silva,Ana Gabriela Henriques
DOI: https://doi.org/10.1111/jnc.15112
2020-08-06
Journal of Neurochemistry
Abstract:Exosomes are small extracellular vesicles released by almost all cell types in physiological and pathological conditions. The exosomal potential to unravel disease mechanisms, or to be used as a source of biomarkers, is being explored, in particularly in the field of neurodegenerative diseases. Alzheimer's disease (AD) is the most prevalent neurodegenerative disease in the world and exosomes appear to have a relevant role in disease pathogenesis. This review summarizes the current knowledge on exosome contributions to AD as well as their use as disease biomarker resources or therapeutic targets. The most recent findings with respect to both protein and miRNA biomarker candidates for AD, herein described, highlight the state of the art in this field and encourage the use of exosomes derived from biofluids in clinical practice in the near future.
biochemistry & molecular biology,neurosciences
What problem does this paper attempt to address?